Literature DB >> 10603517

Characteristics of Myocardial Infarction Episodes in Two Distant Communities: From the REGICOR Registry in Girona, Spain and the MITI Registry in Greater Seattle, USA.

.   

Abstract

Background: The objective of the study is to compare patient characteristics and outcome after myocardial infarction (MI) between two geographically and socially different communities. Methods/
Results: The study was designed as an ecological comparison between a 1-year hospital registry of consecutive MIs in Seattle (1,400,000 inhabitants and a predominantly urban and suburban distribution) and nine hospitals in Giroma (500,000 inhabitants in a predominantly rural distribution). Hospitalization rates for MI are higher in Seattle (standardized rates of 2.5/1000 for men and 0.8/1000 for women) than in Girona (1.5/1000 for men and 0.2/1000 for women). In both registries men under age 60 accounted for 45.5% of cases. Women accounted for 25% of all MI episodes in Seattle and for only 16% in Giromi. Treatment with thrombolytic and beta-blocking drugs was twice as common in Seattle hospitals as in Girona. Hospital mortality in tertiary care hospitals was similar in both registries, but mortality in local hospitals (having no coronary care unit) in Giroma was significantly higher than other hospital mortality rates for MI. Conclusions: The higher in-hospital mortality rate may in large part be explained by the absence of a coronary care unit. However, the dispersion of Girona's population and the lack of specific programs to provide emergent specialized care to possible MI patients may also contribute to the higher in-hospital mortality rate in Girona.

Entities:  

Year:  1994        PMID: 10603517     DOI: 10.1007/BF01062001

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  14 in total

1.  [Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].

Authors: 
Journal:  Rev Esp Cardiol       Date:  1989-02       Impact factor: 4.753

2.  Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986: the Minnesota Heart Survey.

Authors:  G L Burke; J M Sprafka; A R Folsom; R V Luepker; S W Norsted; H Blackburn
Journal:  Int J Epidemiol       Date:  1989       Impact factor: 7.196

3.  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.

Authors: 
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

4.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

5.  [Ten-year survival of a cohort of 736 patients with a first myocardial infarction. Sex-related differences?].

Authors:  J Marrugat; J Sala; A Ribalta; F Sanz
Journal:  Rev Esp Cardiol       Date:  1991-05       Impact factor: 4.753

6.  [Sudden cardiac death in the counties of Girona].

Authors:  G Pérez; J Marrugat; J Sunyer; J Sala
Journal:  Med Clin (Barc)       Date:  1992-10-24       Impact factor: 1.725

7.  Myocardial infarction in Girona, Spain: attack rate, mortality rate and 28-day case fatality in 1988. Regicor Study Group.

Authors:  G Pérez; J Marrugat; J Sala
Journal:  J Clin Epidemiol       Date:  1993-10       Impact factor: 6.437

8.  The time factor in resuscitation initiated by ambulance drivers.

Authors:  C Torp-Pedersen; E Birk-Madsen; A Pedersen
Journal:  Eur Heart J       Date:  1989-06       Impact factor: 29.983

9.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

10.  Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.